03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Solian Tablets 400mg* : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Manufacturer | Sanofi Winthrop Industrie |
Origin | France |
ATC | N05AL05 |
Solian Tablets 400mg* :
Solian Tablets 400mg* :
Solian Tablets 400mg* :
Solian Tablets 400mg* :
Solian Tablets 400mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Solian Tablets 400mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute dystonia | Common |
Agitation | Common |
Agranulocytosis | Not known |
Akathisia | Very Common |
Allergic reaction | Uncommon |
Amenorrhoea (amenorrhea) | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anxiety | Common |
Blood prolactin increased | Common |
Bradycardia | Uncommon |
Breast tension | Common |
Cardiac arrest | Not known |
Confusion | Not known |
Constipation | Common |
Convulsive disorder | Uncommon |
Deep vein thrombosis | Not known |
Dry mouth (Xerostomia) | Common |
Dyskinesia | Very Common |
Erectile dysfunction | Common |
Extrapyramidal symptoms | Very Common |
Frigidity | Common |
Galactorrhoea | Common |
Gynecomastia (Gynaecomastia) | Common |
Hepatic enzyme increased | Uncommon |
Hypercholesterolaemia | Not known |
Hyperglycaemia | Uncommon |
Hypersalivation | Very Common |
Hypertonia | Very Common |
Hypertriglyceridaemia | Not known |
Hypokinesia | Very Common |
Hypotension | Common |
Insomnia | Common |
Leucopenia (Leukopenia) | Not known |
Nausea | Common |
Neuroleptic malignant syndrome | Not known |
Neutropenia | Not known |
Oculogyric crisis | Common |
Pulmonary embolism | Not known |
QT interval prolonged (QT prolongation) | Not known |
Somnolence | Common |
Spasmodic torticollis | Common |
Sudden death | Not known |
Tardive dyskinesia | Uncommon |
Thromboembolism venous | Not known |
Torsade de pointes | Not known |
Transaminases increased | Uncommon |
Tremor | Very Common |
Trismus | Common |
Urticaria | Not known |
Ventricular arrhythmia | Not known |
Ventricular fibrillation | Not known |
Ventricular tachycardia | Not known |
Vomiting | Common |
Weight increased (weight gain) | Common |
Withdrawal syndrome neonatal | Not known |
Solian Tablets 400mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Solian Tablets 400mg* MoH 3078 :
Form | Tablet, Scored |
Packaging | Blisters (Al/PVC) |
Package Size | Box of 30 |
Strength | 400mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 973473/02 |
Submission date | 01/01/2002 |
Registration Year | 2002 |
Withdrawn Date | 2014 |
Price Comparison
● Country: | Germany | |
● Package Size: | 50 | |
● Public Price: | 58.45 EUR | ( 5,662,402.20 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 1,169 EUR | ( 96,876.00 LBP ) |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File